Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 2 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 12329780

    Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphenic materials for use thereof

    The Board of Regents of the University of Texas System · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  2. US 12331130

    DDR1 antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  3. US 12329756

    Regulation of eIF4E activity for migraine therapy

    The Board of Regents of the University of Texas System · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  4. US 12329744

    Methods of preparing extrudates

    The Board of Regents of the University of Texas System · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  5. US 12331110

    Monoclonal antibodies against endotrophin and the use thereof

    The Board of Regents of the University of Texas System · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  6. US 12325705

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  7. US 12325747

    Human PD-L1 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  8. US 12325691

    Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain

    The Board of Regents of the University of Texas System · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  9. US 12318413

    Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

    The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  10. US 12319744

    Treatment and prevention of hemophilic arthropathy with an antibody against endothelial cell protein C receptor (EPCR)

    The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  11. US 12319740

    Methods for production of tissue resident memory-like T cells and use thereof

    The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  12. US 12318439

    Attenuating viral mutations in protein genes

    The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  13. US 12311030

    Antibody-sting agonist conjugates and their use in immunotherapy

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted
  14. US 12310986

    Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxidative stress

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted
  15. US 12310988

    BCMA chimeric antigen receptors and uses thereof

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted
  16. US 12310996

    Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted
  17. US 12304930

    Prefusion-stabilized hMPV F proteins

    The Board of Regents of the University of Texas System · Granted May 20, 2025 · Expires May 15, 2045

    granted
  18. US 12303594

    Antimicrobial and anti-inflammatory compositions

    The Board of Regents of the University of Texas System · Granted May 20, 2025 · Expires May 15, 2045

    granted
  19. US 12297259

    Aspergillus antigen chimeric receptors and use thereof

    The Board of Regents of the University of Texas System · Granted May 13, 2025 · Expires May 8, 2045

    granted
  20. US 12286406

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  21. US 12280088

    Dry powder formulation of caveolin-1 peptides and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  22. US 12280089

    Dry powder formulation of caveolin-1 peptides and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  23. US 12281078

    Quinoline cGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  24. US 12275781

    Monoclonal antibodies against MHC-bound human dickkopf-1 peptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted